| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.95B | +23.3% |
| Cost of Revenue | $365.6M | +30.0% |
| R&D Expense | $411.8M | +28.7% |
| SG&A Expense | $520.3M | -0.9% |
| Operating Income | $200.5M | +76.4% |
| Pre-tax Income | $268.0M | +110.4% |
| Income Tax | $89.1M | +20.4% |
| Net Income | $178.9M | +235.2% |
| EPS (Basic) | $0.37 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $895.1M | -13.1% |
| Short-term Investments | $485.2M | +16.6% |
| Accounts Receivable | $2.87B | +22.3% |
| Current Assets | $4.31B | +12.2% |
| Total Assets | $4.89B | +11.6% |
| Current Liabilities | $2.51B | +23.7% |
| Total Liabilities | $2.72B | +20.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $598.3M | +9.0% |
| Capital Expenditures | $46.8M | -44.4% |
| Investing Cash Flow | -$107.6M | +64.7% |
| Financing Cash Flow | -$626.1M | -2057.1% |
| Free Cash Flow | $551.5M | +18.7% |
| +236.4% |
| EPS (Diluted) | $0.36 | +227.3% |
| Stockholders' Equity |
| $2.16B |
| +2.3% |